An Excel spreadsheet containing data related to our study with six tabs: 1) analysis of the top 150 genes from age prototype classifier in PUBMED; 2) the top 670 genes from the first stage of the project; 3) phenodata for the training data set and validation data sets in our study; 4) a list of prior markers in the literature for Alzheimerâs disease; 5) positional gene enrichment analysis; 6) sample information for the BrainEac study. (XLSX 221 kb
Table S1. iTRAQ quantified human brain proteome of AD individuals and their age-matched control. The...
This document contains Supplementary Tables S1â16, plus their associated legends/captions. (XLSX 6...
DEGs identified in this study. A full list of the 1046 DEGs identified in this meta-analysis in an E...
Table S1. Comparison of module genes identified by lmQCM and WGCNA from GSE48350 AD samples. (XLSX 1...
Figure S1. A cumulative ranking metric of the healthy ageing metric was prognostic for mortality ove...
335 AD-associated genes. The datasets collected from public Alzheimer’s disease databases (AlzGene) ...
Figure S2. Diabetes and vascular disease plots. The healthy aging signature activation was studied i...
Table S1. Brain sample set analyzed in our study. Table S2. RT-qPCR and bisulfite PCR primers. Table...
Table S2. List of 30âAD-specific modules and 31 normal-specific modules. (XLSX 27 kb
Table S1. Sample List. AD, Alzheimer’s disease; AS, asymptomatic Alzheimer’s disease; CT, control; M...
Figure S9. Nanostring dataset for RNA analysis of CDR rated patients and age-matched controls. (XLSX...
Table S2. Cut-offs used for defining pre-clinical Alzheimer’s disease according biomarkers positivit...
Table S1. Cases and controls included. Table S2. QC-passed SNPs analyzed in datasets. Table S3. Geno...
Table S2. Case Characteristics. Values shown are means ± SD. AD, Alzheimer’s disease; AsymAD, asympt...
Table S1. Demographic and neuropathological data of human AD patient and control cases. For each cas...
Table S1. iTRAQ quantified human brain proteome of AD individuals and their age-matched control. The...
This document contains Supplementary Tables S1â16, plus their associated legends/captions. (XLSX 6...
DEGs identified in this study. A full list of the 1046 DEGs identified in this meta-analysis in an E...
Table S1. Comparison of module genes identified by lmQCM and WGCNA from GSE48350 AD samples. (XLSX 1...
Figure S1. A cumulative ranking metric of the healthy ageing metric was prognostic for mortality ove...
335 AD-associated genes. The datasets collected from public Alzheimer’s disease databases (AlzGene) ...
Figure S2. Diabetes and vascular disease plots. The healthy aging signature activation was studied i...
Table S1. Brain sample set analyzed in our study. Table S2. RT-qPCR and bisulfite PCR primers. Table...
Table S2. List of 30âAD-specific modules and 31 normal-specific modules. (XLSX 27 kb
Table S1. Sample List. AD, Alzheimer’s disease; AS, asymptomatic Alzheimer’s disease; CT, control; M...
Figure S9. Nanostring dataset for RNA analysis of CDR rated patients and age-matched controls. (XLSX...
Table S2. Cut-offs used for defining pre-clinical Alzheimer’s disease according biomarkers positivit...
Table S1. Cases and controls included. Table S2. QC-passed SNPs analyzed in datasets. Table S3. Geno...
Table S2. Case Characteristics. Values shown are means ± SD. AD, Alzheimer’s disease; AsymAD, asympt...
Table S1. Demographic and neuropathological data of human AD patient and control cases. For each cas...
Table S1. iTRAQ quantified human brain proteome of AD individuals and their age-matched control. The...
This document contains Supplementary Tables S1â16, plus their associated legends/captions. (XLSX 6...
DEGs identified in this study. A full list of the 1046 DEGs identified in this meta-analysis in an E...